B H Stricker
Overview
Explore the profile of B H Stricker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
249
Citations
2534
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pronk A, van Poelgeest E, Seppala L, Ploegmakers K, Stricker B, Swart K, et al.
Eur Geriatr Med
. 2023 Jan;
14(1):89-97.
PMID: 36656485
Purpose: Antidepressants are well-established fall-risk increasing drugs (FRIDs) and therefore falls should be considered an important adverse drug event (ADE) of antidepressants. However, not all antidepressant users experience fall incidents...
2.
Siland J, Geelhoed B, Roselli C, Wang B, Lin H, Weiss S, et al.
PLoS One
. 2022 May;
17(5):e0268768.
PMID: 35594314
Background: Both elevated and low resting heart rates are associated with atrial fibrillation (AF), suggesting a U-shaped relationship. However, evidence for a U-shaped causal association between genetically-determined resting heart rate...
3.
Pronk A, Seppala L, Trajanoska K, Stringa N, van de Loo B, de Groot L, et al.
PLoS One
. 2022 Apr;
17(4):e0266590.
PMID: 35421149
Background: Antidepressant use has been associated with increased fall risk. Antidepressant-related adverse drug reactions (e.g. orthostatic hypotension) depend partly on genetic variation. We hypothesized that candidate genetic polymorphisms are associated...
4.
van den Boom A, Lavrijssen B, Fest J, Ikram M, Stricker B, van Eijck C, et al.
Cancer Epidemiol
. 2022 Mar;
77:102120.
PMID: 35228019
Background: The appendix, an organ of immunological and microbiological importance, could be involved in the pathogenesis of cancers, but results are inconclusive. Our objective was to assess the association between...
5.
Seppala L, van de Loo B, Schut M, van Schoor N, Stricker B, Kenny R, et al.
Drugs Aging
. 2021 Jul;
38(9):797-805.
PMID: 34224104
Introduction: Several medication classes are considered to present risk factors for falls. However, the evidence is mainly based on observational studies that often lack adequate adjustment for confounders. Therefore, we...
6.
Mulder M, Arp P, Kiefte-de Jong J, Uitterlinden A, Klaassen C, Kraaij R, et al.
Int J Antimicrob Agents
. 2021 Jun;
58(3):106388.
PMID: 34161788
Introduction: Increasing resistance to beta-lactam antibiotics is an alarming development worldwide. Fecal carriership of TEM, SHV, CTX-M and CMY was studied in a community-dwelling population of middle-aged and elderly individuals....
7.
Hendriksen L, van der Linden P, Lagro-Janssen A, van den Bemt P, Siiskonen S, Teichert M, et al.
Biol Sex Differ
. 2021 May;
12(1):34.
PMID: 33941259
Background: Adverse drug events, including adverse drug reactions (ADRs), are responsible for approximately 5% of unplanned hospital admissions: a major health concern. Women are 1.5-1.7 times more likely to develop...
8.
Mulder M, Radjabzadeh D, Kiefte-de Jong J, Uitterlinden A, Kraaij R, Stricker B, et al.
Gut Microbes
. 2020 Sep;
12(1):1795492.
PMID: 32991820
Introduction: Antimicrobial drugs are known to have effects on the human gut microbiota. We studied the long-term temporal relationship between several antimicrobial drug groups and the composition of the human...
9.
Cheung K, El Marroun H, Dierckx B, Visser L, Stricker B
Child Psychiatry Hum Dev
. 2020 Jun;
52(2):332-342.
PMID: 32566998
Multiple factors may contribute to the decision to initiate methylphenidate treatment in children such as maternal sociodemographic factors of which relatively little is known. The objective was to investigate the...
10.
Visser S, Koolen S, de Bruijn P, Belderbos H, Cornelissen R, Mathijssen R, et al.
Eur J Cancer
. 2019 Sep;
121:64-73.
PMID: 31561135
Background: We explored whether total exposure to pemetrexed predicts effectiveness and toxicity in advanced non-small-cell lung cancer (NSCLC). Furthermore, we investigated alternative dosing schedules. Methods: In this prospective cohort study,...